Chris J. Janse

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 116 publications

Bradykinin contributes to vasogenic edema in murine experimental cerebral malaria.

Bradykinin contributes to vasogenic edema in murine experimental cerebral malaria.

Journal: The Journal of clinical investigation
Published: July 14, 2026

Bradykinin Contributes to Vasogenic Edema in Murine Experimental Cerebral Malaria.

Bradykinin Contributes to Vasogenic Edema in Murine Experimental Cerebral Malaria.

Journal: bioRxiv : the preprint server for biology
Published: May 13, 2026

Bradykinin contributes to vasogenic edema in murine experimental cerebral malaria.

Bradykinin contributes to vasogenic edema in murine experimental cerebral malaria.

Journal: The Journal of clinical investigation
Published: November 24, 2025

Safety and Efficacy of Immunization with a Late-Liver-Stage Attenuated Malaria Parasite.

Safety and Efficacy of Immunization with a Late-Liver-Stage Attenuated Malaria Parasite.

Journal: The New England journal of medicine
Published: November 20, 2024

Erythrocyte Membrane Protein 3 (EMAP3) Is Exposed on the Surface of the Plasmodium berghei Infected Red Blood Cell.

Erythrocyte Membrane Protein 3 (EMAP3) Is Exposed on the Surface of the Plasmodium berghei Infected Red Blood Cell.

Journal: Molecular microbiology
Published: November 16, 2024

Synergistic blockade of TIGIT and PD-L1 increases type-1 inflammation and improves parasite control during murine blood-stage Plasmodium yoelii non-lethal infection.

Synergistic blockade of TIGIT and PD-L1 increases type-1 inflammation and improves parasite control during murine blood-stage Plasmodium yoelii non-lethal infection.

Journal: Infection and immunity
Published: September 26, 2024

Severe malaria enforces short-lived effector cell differentiation but does not prevent effective secondary responses by memory CD8 T cells.

Severe malaria enforces short-lived effector cell differentiation but does not prevent effective secondary responses by memory CD8 T cells.

Journal: PLoS pathogens
Published: September 09, 2024

Single immunization with genetically attenuated Pf∆mei2 (GA2) parasites by mosquito bite in controlled human malaria infection: a placebo-controlled randomized trial.

Single immunization with genetically attenuated Pf∆mei2 (GA2) parasites by mosquito bite in controlled human malaria infection: a placebo-controlled randomized trial.

Journal: Nature medicine
Published: June 27, 2024

Variable long-term protection by radiation-, chemo-, and genetically-attenuated Plasmodium berghei sporozoite vaccines.

Variable long-term protection by radiation-, chemo-, and genetically-attenuated Plasmodium berghei sporozoite vaccines.

Journal: Vaccine
Published: September 20, 2023

Sporozoite immunization: innovative translational science to support the fight against malaria.

Sporozoite immunization: innovative translational science to support the fight against malaria.

Journal: Expert review of vaccines
Published: August 12, 2023

The effect of dosage on the protective efficacy of whole-sporozoite formulations for immunization against malaria.

The effect of dosage on the protective efficacy of whole-sporozoite formulations for immunization against malaria.

Journal: NPJ vaccines
Published: July 26, 2023

Author Correction: Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model.

Author Correction: Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model.

Journal: NPJ vaccines
Published: June 05, 2023
Showing 1-12 of 116

Last Updated: 09/26/2026